Navigation Links
Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
Date:5/22/2013

New York, NY (PRWEB) May 22, 2013

Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research was presented at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.

“Patients with type 1 diabetes who have better access to healthcare are more likely to use insulin pump therapy, but even after adjusting for these differences in multivariable modeling we found that insulin pump therapy is a significant predictor of patients’ clinical outcomes,” said Shaloo Gupta, MS, senior research analyst with Kantar Health. “In particular, patients with type 1 diabetes using insulin pump therapy are more likely to control their diabetes than those who are taking insulin injections.”

Patients with T1D who use insulin pump therapy reported significantly lower levels of HbA1C than patients who take multiple daily insulin injections. Nearly 40 percent of those using insulin pump therapy reported HbA1C levels of less than 7 percent, which is considered to be controlled, versus 24 percent of patients using insulin injections.

“Having consistently high HbA1C levels can increase the risk of developing microvascular and macrovascular complications, such as cardiovascular disease, kidney failure, blindness and neuropathy, among those with diabetes,” Gupta said. “Our research suggests that insulin pump therapy is associated with lower blood sugar levels and therefore may lower the risks of these serious complications.”

Visit Kantar Health’s website to download the full poster, “The Effect of Insulin Pump Therapy on HbA1C among Those with Type 1 Diabetes.”

About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2009, 2010, 2011 and 2012 U.S. NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10743580.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tiny RNA molecule may have role in polycystic ovary syndrome, insulin resistance
2. Case Western Reserve receives Helmsley Trust grant to develop new glucose-sensitive insulin
3. Taking insulin for type 2 diabetes could expose patients to greater risk of health complications
4. Binge drinking increases risk of Type 2 diabetes by causing insulin resistance
5. Stop diabetes with insulin tablets
6. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
7. Single gene cause of insulin sensitivity may offer insight for treating diabetes
8. Scientists ID Gene for Insulin Sensitivity
9. New marker for identifying precursors to insulin-producing cells in pancreas
10. Link between brain insulin resistance, neuronal stress in worsening Alzheimers disease
11. No Cancer Risk From Long-Acting Insulin: Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: